search
Back to results

Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy

Primary Purpose

Dental Caries, Oral Cavity Cancer, Oral Complications of Chemotherapy and Head/Neck Radiation

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tray
Brush
Sponsored by
A.T. Still University of Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dental Caries

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 years and older
  • Diagnosis of cancer in the head and neck region
  • Field of radiation must include the parotid gland(s) and/or submandibular gland region
  • Able to speak English
  • Able to provide consent
  • Able to return for all study visits

Exclusion Criteria:

  • Previous/current use of prescription strength fluoride
  • Previous history of radiation to the head and neck region
  • Presence of autoimmune disease(s)
  • Currently pregnant
  • Currently edentulous or will become edentulous prior to beginning radiation therapy

Sites / Locations

  • A.T. Still University, Arizona School of Dentistry & Oral Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Tray group

Brush group

Arm Description

Control intervention Patients will use the custom-made tray to apply the fluoride locally to the teeth and wear for 5 minutes each day.

Patients will brush with the fluoride for 2 minutes each day.

Outcomes

Primary Outcome Measures

Fluoride use compliance
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Fluoride use compliance
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Fluoride use compliance
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Fluoride use compliance
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.

Secondary Outcome Measures

Dental caries incidence assessed at 4 time points
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Dental caries incidence assessed clinically at 4 time points
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Dental caries incidence assessed at 4 time points
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Dental caries incidence assessed at 4 time points
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).

Full Information

First Posted
August 14, 2017
Last Updated
November 22, 2021
Sponsor
A.T. Still University of Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT03267914
Brief Title
Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy
Official Title
Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
August 29, 2017 (Actual)
Primary Completion Date
November 22, 2021 (Actual)
Study Completion Date
November 22, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
A.T. Still University of Health Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Approximately 40 people will participate in this study. This study will compare two different methods of fluoride application. Both methods are currently used in dental practice and both have been shown to be effective. If the participant chooses to participate in this study, participant will be asked to either wear a small tray that has been custom made to fit into the mouth into which fluoride is placed and worn for 5 minutes at bedtime, or participant will be asked to brush fluoride onto the teeth for 2 minutes at bedtime. Participant will be randomly assigned to use one of these methods of fluoride application: participant will not be allowed to choose which method of application you prefer. Participant will be asked to use fluoride every night while enrolled in the study. The fluoride that is used in the study is approved by the United States Food and Drug Administration and is commercially available with a prescription. After the study is over, participant will need to continue to use fluoride every night for life to help reduce the risk for dental cavities in the future. During the study, participant will receive a dental examination every 3 months for a total of 4 study visits over the period of 1 year. This visit will consist of a dental examination to identify any new cavities and instructions for fluoride use. Participant will also be asked to complete a written log to document daily fluoride use and to give feedback about compliance with fluoride use.
Detailed Description
This research proposal is unique in that it compares two different methods of applying neutral sodium fluoride to prevent dental caries and improve compliance in this at-risk population. Given that compliance with use of fluoride trays has historically been poor, there is controversy as to which application method is best. Further, the optimal dosage regimen is unknown. Clarification is needed to support best practices. Data from the proposed study will help to identify an effective and tolerated form of fluoride delivery in patients undergoing head and neck radiation therapy. If our hypotheses are supported, additional studies will be undertaken with a larger sample size, and expanded to include patients with head and neck cancers treated with chemotherapy or a combination of cancer therapies. All patients will undergo an initial dental visit, which will consist of medical consultation with the patient's oncologist and standard dental and radiographic examinations. Patients will return to have existing dental disease treated (eg. caries, gingival disease, extractions). When treatment is complete, they will be invited to participate in the study. The Screening Form will be used to confirm eligibility. Study Visit #1 (Baseline) After obtaining consent, subjects will be randomly assigned to receive fluoride therapy with either custom trays (Tray group) or by application with a toothbrush (Brush group). Each subject will undergo a basic dental examination for identification of new carious lesions. Visit #1 is the baseline, with a new caries score of zero. Photographs will be taken of the subject's mouth and instructions for fluoride therapy will be given. Tray group: The subject will have custom vinyl vacuform fluoride trays made using an in-house laboratory. They will be instructed to apply a "ribbon" of fluoride gel into each tray, and then to wear each tray for 5 minutes, one tray at a time, after which the subject will expectorate any remaining fluoride from the mouth. Brush group: The subject will be instructed to apply a "ribbon" of fluoride gel onto the toothbrush provided (Colgate Wave Sensitive) and to brush with the fluoride for 2 minutes at bedtime. Both groups: The subject may not rinse, eat, or drink for 30 minutes after the fluoride treatment. All subjects will be instructed to perform their fluoride therapy at bedtime and to document the date and time of treatment on the Monthly Fluoride Log. All subjects will be provided with 1.1% neutral sodium fluoride (PreviDent®) gel for the duration of the study. All subjects will be instructed to return their monthly fluoride logs and any remaining fluoride at each study visit. Subjects will return for a follow-up examination at 3, 6, 9, and 12 months from the first study visit. At each visit, the following procedures will be conducted: Update medical history Take photographs Conduct examination for caries Assess compliance with fluoride therapy Collect fluoride log for previous 3 months Dispense new fluoride log Collect and weigh returned fluoride tube Weigh and dispense new fluoride tube Dispense new toothbrush (Brush group only) Subjects will be scheduled to immediately return to have any new carious lesions filled. To evaluate compliance, subjects will be asked about their fluoride use according to standard methods utilized by other experts in the field. High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week. To evaluate caries incidence, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay). Bitewing radiographs and periapical films (as needed) will be taken at 6 and 12 months after the initial examination visit. Descriptive statistics, including means (standard deviations) or counts (percentages), as appropriate, will be used to summarize baseline demographic and clinical characteristics of the two groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries, Oral Cavity Cancer, Oral Complications of Chemotherapy and Head/Neck Radiation

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Subjects will be randomly assigned to receive fluoride therapy with either custom trays (Tray group) or by application with a toothbrush (Brush group).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tray group
Arm Type
Experimental
Arm Description
Control intervention Patients will use the custom-made tray to apply the fluoride locally to the teeth and wear for 5 minutes each day.
Arm Title
Brush group
Arm Type
Active Comparator
Arm Description
Patients will brush with the fluoride for 2 minutes each day.
Intervention Type
Other
Intervention Name(s)
Tray
Intervention Description
Control intervention Patients will use the custom-made tray to apply the fluoride locally to the teeth and wear for 5 minutes each day.
Intervention Type
Other
Intervention Name(s)
Brush
Intervention Description
Patients will brush with the fluoride for 2 minutes each day.
Primary Outcome Measure Information:
Title
Fluoride use compliance
Description
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Time Frame
3 months
Title
Fluoride use compliance
Description
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Time Frame
6 months
Title
Fluoride use compliance
Description
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Time Frame
9 months
Title
Fluoride use compliance
Description
To evaluate compliance, subjects will be asked about their fluoride use according to methods described by Epstein et al. (1996). High compliance is defined as daily use; low compliance is defined as two to three times per week; not compliant is defined as less than two times per week.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Dental caries incidence assessed at 4 time points
Description
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Time Frame
3 months
Title
Dental caries incidence assessed clinically at 4 time points
Description
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Time Frame
6 months
Title
Dental caries incidence assessed at 4 time points
Description
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Time Frame
9 months
Title
Dental caries incidence assessed at 4 time points
Description
To evaluate caries incidence clinically, the number of surfaces per tooth on which new caries appear will be documented on the Caries Assessment Form. Caries will be scored using the International Caries Classification and Management System criteria for clinical research. Surfaces will be scored as either I (no obvious decay) or II (obvious decay).
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Dental caries incidence assessed radiographically at 2 time points
Description
To evaluate caries incidence radiographically, bitewing radiographs and periapical films (as needed) will be taken at 6 and 12 months after the initial examination visit.
Time Frame
6 months
Title
Dental caries incidence assessed radiographically at 2 time points
Description
To evaluate caries incidence radiographically, bitewing radiographs and periapical films (as needed) will be taken at 6 and 12 months after the initial examination visit.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 years and older Diagnosis of cancer in the head and neck region Field of radiation must include the parotid gland(s) and/or submandibular gland region Able to speak English Able to provide consent Able to return for all study visits Exclusion Criteria: Previous/current use of prescription strength fluoride Previous history of radiation to the head and neck region Presence of autoimmune disease(s) Currently pregnant Currently edentulous or will become edentulous prior to beginning radiation therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Seena Patel, DMD, MPH
Organizational Affiliation
A.T. Still University, Arizona School of Dentistry & Oral Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
A.T. Still University, Arizona School of Dentistry & Oral Health
City
Mesa
State/Province
Arizona
ZIP/Postal Code
85206
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Impact of Compliance With Fluoride Use on Caries Incidence After Cancer Therapy

We'll reach out to this number within 24 hrs